By Authors

Publications - sorted by Authors

• Dal-Bianco A, Schranzer R, Grabner G, Lanzinger M, Kolbrink S, Pusswald G, Altmann P, Ponleitner M, Weber M, Kornek B, Zebenholzer K, Schmied C, Berger T, Lassmann H, Trattnig S, Hametner S, Leutmezer F, Rommer P (2021) Iron Rims in Patients With Multiple Sclerosis as Neurodegenerative Marker? A 7-Tesla Magnetic Resonance Study Front Neurol, 12: 632749

• Reinthaler E, Graf E, Zrzavy T, Wieland T, Hotzy C, Kopecky C, Pferschy S, Schmied C, Leutmezer F, Keilani M, Lill C, Hoffjan S, Epplen J, Zettl U, Hecker M, Deutschländer A, Meuth S, Ahram M, Mustafa B, El-Khateeb M, Vilariño-Güell C, Sadovnick A, Zimprich F, Tomkinson B, Strom T, Kristoferitsch W, Lassmann H, Zimprich A (2018) TPP2 mutation associated with sterile brain inflammation mimicking MS Neurol Genet, 4 (6): e285
• Zrzavy T, Kovacs-Nagy R, Reinthaler E, Deutschländer A, Schmied C, Kornek B, Leutmezer F, Zimprich A (2018) A rare P2RX7 variant in a Hungarian family with Multiple Sclerosis Mult Scler Relat Disord.,

• Reinthaler EM, Graf E, Zrzavy T, Wieland T, Hotzy C, Kopecky CM, Schmied C, Leutmezer FH, Keilani MY, Lill CM, Hoffjan S, Epplen JT, Zettl UK, Hecker M, Deutschlaender A, Ahram M, Mustafa B, El-Khateeb M, Vilarino-Guell C, Sadovnick DA, Zimprich F, Tomkinson B, Strom TM, Kristoferitsch W, Lassmann H, Zimprich A (2016) Mutations in the gene tripeptidyl peptidase II (TPP2) and multiple sclerosis Mult Scler, 22: 849
• Sadovnick A, Traboulsee A, Bernales C, Ross J, Forwell A, Yee I, Guillot-Noel L, Fontaine B, Cournu-Rebeix I, Alcina A, Fedetz M, Izquierdo G, Matesanz F, Hilven K, Dubois B, Goris A, Astobiza I, Alloza I, Antiguedad A, Vandenbroeck K, Akkad D, Aktas O, Blaschke P, Buttmann M, Chan A, Epplen J, Gerdes L, Kroner A, Kubisch C, Kumpfel T, Lohse P, Rieckmann P, Zettl U, Zipp F, Bertram L, Lill C, Fernandez O, Urbaneja P, Leyva L, Alvarez-Cermeno J, Arroyo R, Garagorri A, Garcia-Martinez A, Villar L, Urcelay E, Malhotra S, Montalban X, Comabella M, Berger T, Fazekas F, Reindl M, Schmied M, Zimprich A, Vilarino-Guell C (2016) Analysis of Plasminogen Genetic Variants in Multiple Sclerosis Patients G3, 6 (7): 2073-2079

• Salhofer-Polanyi S, Baumgartner A, Kraus J, Maida E, Schmied M, Leutmezer F, (2014) What to expect after natalizumab cessation in a real-life setting Acta Neurol Scand, 130 (2): 97-102
• Schmied C (2014) T-Cells Show Increased Production of Cytokines and Activation Markers in Alzheimer’s Disease Brain Disord Ther, 03 (01)

• Reinthaler E, Machetanz G, Hotzy C, Reindl M, Fazekas F, Kristoferitsch W, Berger T, Schmied C, Zimprich A (2013) No evidence for a role of rare CYP27B1 variants in Austrian multiple sclerosis patients Mult Scler, 20 (3): 391-392

• Schmied M, Zehetmayer S, Reindl M, Ehling R, Bajer-Kornek B, Leutmezer F, Zebenholzer K, Hotzy C, Lichtner P, Meitinger T, Wichmann H, Illig T, Gieger C, Huber K, Khalil M, Fuchs S, Schmidt H, Auff E, Kristoferitsch W, Fazekas F, Berger T, Vass K, Zimprich A (2012) Replication study of multiple sclerosis (MS) susceptibility alleles and correlation of DNA-variants with disease features in a cohort of Austrian MS patients Neurogenetics, 13 (2): 181-187

• Stogmann E, Lichtner P, Baumgartner C, Schmied M, Hotzy C, Asmus F, Leutmezer F, Bonelli S, Assem-Hilger E, Vass K, Hatala K, Strom TM, Meitinger T, Zimprich F, Zimprich A (2006) Mutations in the CLCN2 gene are a rare cause of idiopathic generalized epilepsy syndromes Neurogenetics,